Nob Hill Therapeutics
Nob Hill Therapeutics is established to commercialize the first dry-powder nebulizer to treat severe respiratory diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€11—16m (Dealroom.co estimates Aug 2024.)
Albuquerque New Mexico (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $113k | Seed | |
$30.0k | Seed | ||
* | $30.0k | Grant | |
* | $3.0m | Series A | |
| Total Funding | €2.9m | ||
Recent News about Nob Hill Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.